Ultrasound Guided Octreotide LAR Injection in Acromegaly
NCT00552071
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Octreotide LAR 30 MG Injection
Sponsor
Cedars-Sinai Medical Center
Collaborators
[object Object]